IDiyas

For the Inventor, By the Inventor

Ibaraki, Japan

Richard S Clark

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 11.8

ph-index = 8

Forward Citations = 253(Granted Patents)


Location History:

  • Tsukuba, JP (2010 - 2012)
  • Ibaraki, JP (1993 - 2013)
  • Tsuchiura, JP (2007 - 2019)

Company Filing History:

goldMedal18 out of 677 
 
Eisai Company, Limited
 patents
silverMedal10 out of 527 
 
Eisai R&d Management Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1993-2019

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):
1. 10227349 - Pyrazolo[1,5-a]pyrimidine compound (2019-03-12),
2. 8436009 - Prodrug of triazolone compound (2013-05-07),
3. 8163787 - Triazolone derivatives (2012-04-24),
4. 7928228 - Triazolone derivatives (2011-04-19),
5. 7816522 - Triazolone derivatives (2010-10-19),
6. 7807690 - 2,3-dihydro-iminoisoindole derivatives (2010-10-05),
7. 7772226 - Condensed imidazole derivatives (2010-08-10),
8. 7687664 - Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it (2010-03-30),
9. 7544835 - Carboxylic acid derivative and salt thereof (2009-06-09),
10. 7524847 - Fused 1,3-dihydro-imidazole ring compounds (2009-04-28),
11. 7371777 - Cyclic compound and PPAR agonist (2008-05-13),
12. 7304083 - 2-iminoimidazole derivatives (2) (2007-12-04),
13. 7253178 - Carboxylic acids (2007-08-07),
14. 7244861 - Benzene compound and salt thereof (2007-07-17),
15. 7244730 - 2-iminopyrrolidine derivatives (2007-07-17),

Title: Richard S Clark: A Trailblazer in the World of Inventions

Introduction:

Richard S Clark, a visionary inventor based in Ibaraki, JP, has carved a name for himself through his passion for innovation and relentless pursuit of excellence. With 27 patents to his name, his contributions have significantly impacted the world of technology and inspired the next generation of inventors.

Latest Patents:

Among his latest patents is the Pyrazolo[1,5-a]pyrimidine compound. This groundbreaking invention exhibits protease-activated receptor 2 (PAR2) inhibitory action, opening new possibilities in pharmaceutical treatments. Additionally, his Prodrug of triazolone compound showcases remarkable potential in addressing diseases related to thrombus formation.

Career Highlights:

Richard S Clark has honed his craft at esteemed companies such as Eisai Company, Limited, and Eisai R&D Management Co., Ltd. His tenure at these organizations has been marked by a commitment to innovation and a drive to push the boundaries of what is achievable in the realm of inventions.

Collaborations:

Throughout his career, Richard S Clark has collaborated closely with notable industry peers, including Fumiyoshi Matsuura and Tetsuya Kawahara. These collaborations have not only fueled his inventive spirit but have also led to the development of groundbreaking technologies that have left a lasting impact on the field.

Conclusion:

In conclusion, Richard S Clark's unwavering dedication to innovation and his trailblazing inventions have cemented his legacy as a luminary in the world of inventions. His work continues to inspire and shape the landscape of technology, propelling us towards a future defined by groundbreaking discoveries and transformative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…